(Q42434037)

31 October 2017

Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension (English)

1 reference

31 October 2017

Allan Lawrie

11

0 references

Phillip Yang

10

object named as

Phillip C Yang

1 reference

31 October 2017

Anton Vonk-Noordegraaf

7

object named as

Anton Vonk Noordegraaf

1 reference

31 October 2017

Edda Spiekerkoetter

1

1 reference

31 October 2017

Yon K Sung

2

1 reference

31 October 2017

Deepti Sudheendra

3

1 reference

31 October 2017

Matthew Bill

4

1 reference

31 October 2017

Micheala A Aldred

5

1 reference

31 October 2017

Mariëlle C van de Veerdonk

6

1 reference

31 October 2017

Janel Long-Boyle

8

1 reference

31 October 2017

Rajesh Dash

9

1 reference

31 October 2017

Andrew J Swift

12

1 reference

31 October 2017

Marlene Rabinovitch

13

1 reference

31 October 2017

Roham T Zamanian

14

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 July 2015

1 reference

American Journal of Respiratory and Critical Care Medicine

31 October 2017

1 reference

31 October 2017

192

1 reference

31 October 2017

2

1 reference

31 October 2017

254-257

1 reference

FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.

31 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Modern age pathology of pulmonary arterial hypertension

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Reversal of experimental pulmonary hypertension by PDGF inhibition

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Treatment of pulmonary arterial hypertension

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532822

10.1164/RCCM.201411-2061LE

16 August 2018

Identifiers

DOI

1 reference

31 October 2017

1 reference

31 October 2017

PubMed publication ID

26177174

1 reference